(Q40374619)

19 September 2017

1 reference

title

Structural aspects of receptor dimerization. c-kit as an example (English)

1 reference

19 September 2017

Blechman JM

1

1 reference

19 September 2017

Yarden Y

series ordinal

2

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

Annals of the New York Academy of Sciences

19 September 2017

published in

1 reference

19 September 2017

volume

766

1 reference

19 September 2017

page(s)

344-362

1 reference

Signalling by receptor tyrosine kinases

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Homodimerization and constitutive activation of the erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

A point mutation in the neu oncogene mimics ligand induction of receptor aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Molecular basis of the activation of the tumorigenic potential of Gag-insulin receptor chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Interspecies molecular chimeras of kit help define the binding site of the stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Identification of a peptide sequence involved in homophilic binding in the neural cell adhesion molecule NCAM

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

Dimerization of cell surface receptors in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

A comparative analysis of disease-associated changes in the galactosylation of serum IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1995.TB26685.X

10.1111/J.1749-6632.1995.TB26685.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference